Have you or someone you know experienced or been affected by alpha-1 antitrypsin deficiency–related lung disease? Your input is needed on a review considering alpha-1 antitrypsin augmentation therapy for people with alpha-1 antitrypsin deficiency–associated lung disease.
Skills / interests: Patient and public input
Would you be interested in helping us with this research article focused on alpha-1 antitrypsin augmentation therapy for people with alpha-1 antitrypsin deficiency–related lung disease?
I am looking for a patient or member of the public who would be willing to peer review this Cochrane systematic review, “Alpha-1 antitrypsin augmentation for alpha-1 antitrypsin deficiency–associated lung disease”.
When we say ‘patients and the public’, we mean patients and potential patients, carers, people who use health and social care services, and people or organizations that represent these groups.
We are interested in whether the language of the review, especially the language used in the Plain Language Summary (PLS), is accessible and feels relevant for those experiencing alpha-1 antitrypsin deficiency–related lung disease, so it will be helpful to patients and members of the public making healthcare decisions. We welcome feedback on any aspect of the review, with particular focus on the PLS section. Our aim is for this to be a manageable task and not overburden our reviewers.
If you are interested in providing peer review, please include your e-mail address in your response. This will allow us to confirm your enrolment in our editorial management system (called Editorial Manager) and ensure that you can receive the review assignment.
Thank you in advance for your consideration!
Ideal applicant
Questions & comments
Cochrane